Investor Presentaiton

Private large portfolio companies EXTERNALLY VALUED A RETAIL (PHARMACY) BUSINESS OVERVIEW 00 Country's largest retailer in terms of both, revenue and number of bills issued Market share by revenue, 20191 BUSINESSES MAJOR GROWTH DRIVERS GHG in pharma PSP Aversi 336 Other 302 500 615 35% 29% 19% 17% > Expending retail footprint › Enhancing retail margin (private label products) > New retail categories such as lab service and beauty GEORGIA CAPITAL > Growing wholesale revenue (such as hospital supplies) > Digital channels Medium to long-term targets ☐ Double digit revenue CAGR 337 Π 9%+ EBITDA margin Operates under two pharmacy brands, each with a distinct positioning: > GPC for the high-end customer segment > Pharmadepot for the mass retail segment 337 Pharmacies countrywide 236 129 136 67 34 38 106 101 69 25 38 9 0 Shopping Areas Clinic 23 Residential area High street Total GPC Pharmadepot Georgia Capital PLC | 1. Total market size 2018 - Frost & Sullivan analysis, revenue distribution between competitors from published audited annual reports 56

View entire presentation